ciprofloxacin has been researched along with End Stage Liver Disease in 2 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
End Stage Liver Disease: Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.
| Excerpt | Relevance | Reference |
|---|---|---|
| "For the treatment of spontaneous bacterial peritonitis (SBP), cefotaxime, ceftriaxone, and ciprofloxacin were used as first-line agents." | 9.69 | Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial: A Validation Study of 2021 AASLD Practice Guidance for SBP. ( Baik, SK; Han, KH; Heo, J; Heo, NY; Jung, YK; Kang, SH; Kim, BI; Kim, HS; Kim, MY; Kim, TH; Kim, YS; Park, JY; Park, SY; Seo, YS; Sohn, JH; Suh, SJ; Um, SH; Yim, HJ; Yim, SY, 2023) |
| "For the treatment of spontaneous bacterial peritonitis (SBP), cefotaxime, ceftriaxone, and ciprofloxacin were used as first-line agents." | 5.69 | Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial: A Validation Study of 2021 AASLD Practice Guidance for SBP. ( Baik, SK; Han, KH; Heo, J; Heo, NY; Jung, YK; Kang, SH; Kim, BI; Kim, HS; Kim, MY; Kim, TH; Kim, YS; Park, JY; Park, SY; Seo, YS; Sohn, JH; Suh, SJ; Um, SH; Yim, HJ; Yim, SY, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yim, HJ | 1 |
| Kim, TH | 1 |
| Suh, SJ | 1 |
| Yim, SY | 1 |
| Jung, YK | 1 |
| Seo, YS | 1 |
| Kang, SH | 1 |
| Kim, MY | 1 |
| Baik, SK | 1 |
| Kim, HS | 1 |
| Kim, YS | 1 |
| Park, SY | 1 |
| Kim, BI | 1 |
| Park, JY | 1 |
| Heo, J | 1 |
| Sohn, JH | 1 |
| Heo, NY | 1 |
| Han, KH | 1 |
| Um, SH | 1 |
| Bert, F | 1 |
| Larroque, B | 1 |
| Dondero, F | 1 |
| Durand, F | 1 |
| Paugam-Burtz, C | 1 |
| Belghiti, J | 1 |
| Moreau, R | 1 |
| Nicolas-Chanoine, MH | 1 |
1 trial available for ciprofloxacin and End Stage Liver Disease
| Article | Year |
|---|---|
Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial: A Validation Study of 2021 AASLD Practice Guidance for SBP.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ascites; Bacterial Infections; Cefotaxime; Ceftriaxo | 2023 |
1 other study available for ciprofloxacin and End Stage Liver Disease
| Article | Year |
|---|---|
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial | 2014 |